On August 21, 2023, the Centers for Medicare and Medicaid Services (CMS) announced a crucial decision to retain HCPCS Level II codes S2066, S2067, and S2068, encompassing DIEP, GAP, and SIEA flaps for autologous breast reconstruction. Initially scheduled for discontinuation on December 31, 2024, the CMS decision followed a public meeting where concerns about the complexity of transitioning and potential impacts on access to care were raised. CMS, having received feedback indicating the private insurance industry's attempt to reclassify microsurgical breast reconstruction as a lower-level procedure, cited these concerns in their decision. The meeting involved participation from diverse stakeholders, including ASPS President Greg Greco, member surgeons, and patients advocating that microsurgical autologous breast reconstruction is vital post-mastectomy, emphasizing the pivotal role of maintaining the S-codes for continued accessibility to the procedure.
Read more at ASPS